Price $19.77 |
Market Cap
2.97B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.86
|
P/S
2.93
|
Dividend %
-
|
|
P/CF
44.1
|
P/FCF
75.8
|
Op. Cash Flow
82.8K
|
FCF
0.2
|
|
Op. Margin
-10.80%
|
Net Margin
-10.70%
|
ROE
-10.40%
|
ROI
-9.40%
|
|
ROA
-5.90%
|
EPS Growth
44.30%
|
Current Ratio
2.5
|
Debt/Equity
25.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ImmuCell Corporation (ICCC) | $9.25 | - | - | 69.5M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.90 | - | - | 2.02B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $64.44 | - | 3.10% | 141.03B | Strong Buy |
| AEterna Zentaris Inc. (USA) (AEZS) | $0.88 | - | - | 133.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.78 | - | - | 217.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
